Skip to content

Member

Sirpa PIETIKÄINEN

EPP · Finland

Group
EPP PPE
Country
Finland
Roll-call participation
89.6 %ⓘ of 5 503 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
85.0 %ⓘ of 4 932 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
KOK Kansallinen Kokoomus
In office
Since 1 Dec 2024
Against clear line
664 of 4 722 votesⓘ
Committees
ECON, ENVI (substitute), FEMM, SANT (substitute)
Member id
40599
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

89.6 %

4 932 of 5 503 roll calls while in office

EPP median: 89.9 % (−0.3 pts)

Chamber median: 90.2 %

With majority line ⓘ

85.0 %

4 194 of 4 932 votes where their group had a line

EPP median: 93.6 % (−8.6 pts)

Against clear line ⓘ

14.1 %

664 of 4 722 votes where their group had a clear line

610 opposite (for ↔ against), 44 abstained against the line, 10 voted for or against when the line was to abstain

Abstention ⓘ

1.1 %

55 of 4 932 votes cast

Participation 89.6 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
Sirpa PIETIKÄINEN89.6 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 85.0 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
Sirpa PIETIKÄINEN85.0 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 572

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
21 Jan 2026Request for opinion from the Court of Justice on the compatibility with the Treaties of the proposed EU-Mercosur Partnership Agreement (EMPA) and Interim Trade Agreement (ITA) Adopted 334 for, 324 against, 11 abstainedPosition: Against Majority line: Against
21 Jan 2026Implementation of the common foreign and security policy – annual report 2025 Adopted 392 for, 179 against, 83 abstainedPosition: For Majority line: For
21 Jan 2026Implementation of the common security and defence policy – annual report 2025 Adopted 395 for, 197 against, 70 abstainedPosition: For Majority line: For
21 Jan 2026Human rights and democracy in the world and the European Union’s policy on the matter – annual report 2025 Adopted 421 for, 120 against, 108 abstainedPosition: For Majority line: For
21 Jan 2026Addressing impunity through EU sanctions, including the EU Global Human Rights sanctions regime (so-called ‘EU Magnitsky Act’) Adopted 440 for, 127 against, 59 abstainedPosition: For Majority line: For
20 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest Passed 503 for, 57 against, 108 abstainedPosition: For Majority line: For
20 Jan 2026The 28th Regime: a new legal framework for innovative companies Adopted 492 for, 144 against, 28 abstainedPosition: For Majority line: For
20 Jan 2026Just transition directive in the world of work: ensuring the creation of jobs and revitalising local economies Adopted 420 for, 207 against, 20 abstainedPosition: For Majority line: For
20 Jan 2026Safeguarding and promoting financial stability amid economic uncertainties Adopted 491 for, 83 against, 84 abstainedPosition: For Majority line: For
20 Jan 2026Humanitarian aid in a time of polycrisis – reaffirming our principles for a more effective and ambitious response to humanitarian crises Adopted 444 for, 153 against, 55 abstainedPosition: For Majority line: For
20 Jan 2026Reform of the European Electoral Act – hurdles to ratification and implementation in the Member States Adopted 417 for, 234 against, 9 abstainedPosition: For Majority line: For
18 Dec 2025Arbitrary arrest and sentencing of academics Bahruz Samadov and Igbal Abilov in Azerbaijan Adopted 477 for, 7 against, 69 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Mass kidnapping of children in Nigeria, including from St Mary’s Catholic School in Papiri Adopted 519 for, 2 against, 50 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Grave political situation in Guinea-Bissau after the coup of 26 November Adopted 535 for, 0 against, 42 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Implementation of the rule of law conditionality regime Adopted 386 for, 184 against, 15 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Decarbonisation and modernisation of EU fisheries, and the development and deployment of fishing gear Adopted 450 for, 93 against, 37 abstainedPosition: No vote recorded Majority line: For
18 Dec 2025Continuous Belarusian hybrid attacks against Lithuania Adopted 438 for, 37 against, 48 abstainedPosition: No vote recorded Majority line: For
17 Dec 2025Application of the ‘safe third country’ concept Negotiating mandate approved 384 for, 237 against, 31 abstainedPosition: For Majority line: For
17 Dec 2025Establishment of a list of safe countries of origin at Union level Negotiating mandate approved 396 for, 202 against, 56 abstainedPosition: For Majority line: For
17 Dec 2025Phasing out Russian natural gas imports, improving monitoring of potential energy dependencies Passed 500 for, 120 against, 32 abstainedPosition: For Majority line: For
17 Dec 2025Deforestation Regulation: certain obligations of operators and traders Passed 405 for, 242 against, 8 abstainedPosition: Against ≠ groupMajority line: For
17 Dec 2025European High Performance Computing Joint Undertaking (EuroHPC) Passed 604 for, 37 against, 18 abstainedPosition: For Majority line: For
17 Dec 2025EU/Jordan Agreement for scientific and technological cooperation: terms and conditions for the participation of Jordan in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA) Consent given 627 for, 13 against, 5 abstainedPosition: For Majority line: For
17 Dec 2025Simplification of the content and presentation of information to be disclosed concerning environmentally sustainable activities and simplification of certain technical screening criteria for determining whether economic activities cause no significant harm to environmental objectives Objection failed 230 for, 402 against, 28 abstainedPosition: For ≠ groupMajority line: Against
17 Dec 2025Military Mobility Adopted 493 for, 127 against, 38 abstainedPosition: For Majority line: For
17 Dec 2025European Defence Readiness 2030: assessment of needs Adopted 425 for, 120 against, 96 abstainedPosition: For Majority line: For
17 Dec 2025Digitalisation, artificial intelligence and algorithmic management in the workplace – shaping the future of work Adopted 480 for, 83 against, 94 abstainedPosition: For Majority line: For
17 Dec 2025European Citizens’ Initiative ‘My voice, my choice: for safe and accessible abortion’ Adopted 358 for, 202 against, 79 abstainedPosition: For Majority line: For
16 Dec 2025Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products Passed 431 for, 161 against, 70 abstainedPosition: For Majority line: For
16 Dec 2025Amending the Directive on alternative dispute resolution for consumer disputes Amendment 1 rejected 122 for, 470 against, 69 abstainedPosition: Against Majority line: Against
16 Dec 2025Incentivising defence-related investments in the EU budget to implement the ReArm Europe Plan Passed 519 for, 119 against, 25 abstainedPosition: For Majority line: For
16 Dec 2025Amending certain CAP Regulations as regards the conditionality system, types of intervention in the form of direct payment, types of intervention in certain sectors and rural development and annual performance reports, data and interoperability governance, suspensions of payments annual performance clearance and controls and penalties Passed 629 for, 17 against, 16 abstainedPosition: For Majority line: For
16 Dec 2025Providing macro-financial assistance to Jordan Passed 585 for, 34 against, 45 abstainedPosition: For Majority line: For
16 Dec 2025Brexit Adjustment Reserve Passed 619 for, 6 against, 37 abstainedPosition: For Majority line: For
16 Dec 2025Corporate sustainability reporting and due diligence requirements Passed 428 for, 218 against, 17 abstainedPosition: Against ≠ groupMajority line: For
16 Dec 2025Mobilisation of the European Globalisation Adjustment Fund for Displaced Workers: application EGF/2025/003 SE/Northvolt – Sweden Passed 578 for, 54 against, 30 abstainedPosition: For Majority line: For
16 Dec 2025Genetically modified maize NK603 Objection passed 479 for, 173 against, 8 abstainedPosition: For Majority line: Against
16 Dec 2025Genetically modified sugar beet KWS20-1 Objection passed 455 for, 169 against, 8 abstainedPosition: For Majority line: Against
16 Dec 2025Relations between the EU and Saudi Arabia Adopted 417 for, 131 against, 108 abstainedPosition: For Majority line: For
27 Nov 2025Amending Regulations on the Internal Market Information System (IMI) and on the single digital gateway as regards certain harmonisation requirements on transparency Passed 400 for, 77 against, 132 abstainedPosition: For Majority line: For
27 Nov 2025Harmonised requirements in the internal market on transparency of third countries interest representation Passed 392 for, 88 against, 133 abstainedPosition: For Majority line: For
27 Nov 2025Post-election killings and the deteriorating human rights situation in Tanzania, including the case of imprisoned opposition leader Tundu Lissu Adopted 539 for, 0 against, 27 abstainedPosition: For Majority line: For
27 Nov 2025Escalating repression of the Baha’is in Iran Adopted 549 for, 7 against, 31 abstainedPosition: For Majority line: For
27 Nov 2025Rule of law and human rights situation in Tunisia, particularly the case of Sonia Dahmani Adopted 464 for, 58 against, 75 abstainedPosition: For Majority line: For
27 Nov 2025Implementation of the EU-UK Trade and Cooperation Agreement Adopted 490 for, 41 against, 74 abstainedPosition: For Majority line: For
27 Nov 2025EU strategy for the rights of persons with disabilities post-2024 Adopted 490 for, 9 against, 109 abstainedPosition: For Majority line: For
27 Nov 2025Application of the Treaty provisions related to the principles of subsidiarity and proportionality and the role of national parliaments in the EU legislative process Adopted 337 for, 245 against, 12 abstainedPosition: No vote recorded Majority line: For
27 Nov 2025Escalation of the war and the humanitarian catastrophe in Sudan Adopted 503 for, 32 against, 52 abstainedPosition: For Majority line: For
27 Nov 2025Political situation in Myanmar including the humanitarian crisis of the Rohingya Adopted 519 for, 3 against, 57 abstainedPosition: For Majority line: For
27 Nov 2025EU position on the proposed plan and EU engagement towards a just and lasting peace for Ukraine Adopted 401 for, 70 against, 90 abstainedPosition: For Majority line: For

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 31 of 88 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Willemien KONING EPPNetherlands87 % of 1 811 shared89 %
Aura SALLA EPPFinland87 % of 4 053 shared89 %
Axel VOSS EPPGermany86 % of 3 754 shared89 %
Isabel WISELER-LIMA EPPLuxembourg86 % of 4 796 shared89 %
Liesbet SOMMEN EPPBelgium86 % of 4 836 shared89 %
Marie-Sophie CHRIST EPPGermany86 % of 1 392 shared89 %
Manuela RIPA EPPGermany86 % of 4 456 shared89 %
Sandra KALNIETE EPPLatvia85 % of 4 619 shared89 %
Martine KEMP EPPLuxembourg85 % of 4 347 shared89 %
Verena MERTENS EPPGermany85 % of 4 277 shared89 %

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Ľudovít ÓDOR RenewSlovakia89 % of 4 580 shared82 %
Yvan VEROUGSTRAETE RenewBelgium89 % of 3 540 shared82 %
Veronika CIFROVÁ OSTRIHOŇOVÁ RenewSlovakia88 % of 3 700 shared82 %
Martin HOJSÍK RenewSlovakia88 % of 4 419 shared82 %
Lucia YAR RenewSlovakia88 % of 4 880 shared82 %
Katarina BARLEY S&DGermany88 % of 3 672 shared75 %
Iratxe GARCÍA PÉREZ S&DSpain88 % of 4 627 shared75 %
Brigitte VAN DEN BERG RenewNetherlands88 % of 4 104 shared82 %
Michal WIEZIK RenewSlovakia88 % of 4 465 shared82 %
Dainius ŽALIMAS RenewLithuania88 % of 4 547 shared82 %

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Economic and Monetary AffairsECON CommitteeMember16 Dec 2024now
Committee on the Environment, Climate and Food SafetyENVI CommitteeSubstitute20 Jan 2025now
Committee on Women’s Rights and Gender EqualityFEMM CommitteeMember16 Dec 2024now
Committee on Public HealthSANT CommitteeSubstitute23 Jan 2025now
Delegation for relations with the People's Republic of ChinaD-CN DelegationSubstitute2 Dec 2024now
Delegation for relations with the Pan-African ParliamentDPAP DelegationMember16 Dec 2024now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on DisabilityIG10-10 Intergroup / working groupMember11 Mar 2025now
Intergroup on Fighting against PovertyIG10-12 Intergroup / working groupMember17 Jun 2025now

Show all 18 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Neurological health strategyShadow rapporteurSANT20 Jul 2026
Union Civil Protection Mechanism and Union support for health emergency preparedness and response, and repealing Decision No 1313/2013/EU (Union Civil Protection Mechanism)Shadow rapporteurSANT23 Apr 2026
Safety, resilience and sustainability of space activities in the UnionShadow rapporteur for an opinionENVI3 Nov 2025
Collection of statistical information by the European Central BankShadow rapporteurECON24 Sept 2025
Developing a new EU anti-poverty strategyShadow rapporteur for an opinionFEMM25 Jun 2025
Gender inequalities in health, specifically as regards gender-specific conditionsShadow rapporteur for an opinionSANT25 Jun 2025

Show all 6 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

23 contributions recorded, 16 written statements; 12 minutes of speaking time.

Show all 23 recent contributions

Questions and motions, 75

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
8 Sept 2026Chatbots directing women with unwanted pregnancies to anti-abortion websites E-10-2026-003539Written questionwith 67 co-authorsNot yet answered
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize MON 87460 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0381Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean GMB151 x DAS-44406-6 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0380Motion for a resolutionwith 3 co-authors—
2 Sept 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 94313 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0379Motion for a resolutionwith 3 co-authors—
16 Jul 2026Ensuring the continued operation of the Blue Flag Programme under Directive (EU) 2024/825 E-10-2026-003031Written questionwith 29 co-authors18 Sept 2026
8 Jul 2026Impact of the recent US Supreme Court ruling on the EU–US Data Privacy Framework and European data sovereignty E-10-2026-002823Written questionwith 21 co-authorsNot yet answered
1 Jul 2026MOTION FOR A RESOLUTION on the draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 87705 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0334Motion for a resolutionwith 3 co-authors—
1 Jul 2026MOTION FOR A RESOLUTION on the draft Commission Implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP202216 x NK603 x DAS-40278-9 and its sub-combinations DP202216 x NK603, DP202216 x DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0336Motion for a resolutionwith 3 co-authors—
1 Jul 2026MOTION FOR A RESOLUTION on the Commission Implementing Decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified maize NK603 × T25 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council B-10-2026-0335Motion for a resolutionwith 3 co-authors—
29 Jun 2026Scrutiny of hunting trophy imports into the EU E-10-2026-002689Written questionwith 8 co-authors25 Aug 2026

Show all 75 questions and motions

Amendments tabled in committee, 126

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT43
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT21
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791136 ECON4
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791135 ECON39
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791103 ECON3
31 Jul 2026on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EU) No 1095/2010, No 648/2012, No 600/2014, No 909/2014, 2015/2365, 2019/1156, 2021/23, 2022/858, 2023/1114, No 1060/2009, 2016/1011, 2017/2402, 2023/2631 and 2024/3005 as regards the further development of capital market integration and supervision within the Union ECON-AM-791134 ECON9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT1
27 Jul 2026on the proposal for a directive of the European Parliament and of the Council amending Directives 2009/65/EC, 2011/61/EU and 2014/65/EU as regards the further development of capital market integration and supervision within the Union ECON-AM-791126 ECON1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ531

Show all 126 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Finland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “Sirpa PIETIKÄINEN”. Member record. memberId 40599. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/40599?nb=all&page=6&rows=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/40599?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-40599,
  author = {{EU Parl Watch Research}},
  title = {{Sirpa PIETIKÄINEN}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/40599?nb=all&page=6&rows=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/40599?nb=all&page=6&rows=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 40599. Official source: https://www.europarl.europa.eu/meps/en/40599. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}